Health
Multidose Vial Presentation of Audenz, an H5N1 Influenza Vaccine, Approved – Monthly Prescribing Reference
Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant.
The Food and Drug Administration (FDA) has approved a multidose vial presentation of Audenz (influenza A
Continue Reading
